Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors.
We reported upregulation of endothelial nitric oxide synthase (eNOS) by PGE(2) in tissues and presence of perinuclear PGE(2) receptors (EP). We presently studied mechanisms by which PGE(2) induces eNOS expression in cerebral microvessel endothelial cells (ECs). 16,16-Dimethyl PGE(2) and selective EP(3) receptor agonist M&B28767 increased eNOS expression in ECs and the NO-dependent vasorelaxant responses induced by substance P on cerebral microvessels. These effects could be prevented by prostaglandin transporter blocker bromcresol green and actinomycin D. EP(3) immunoreactivity was confirmed on plasma and perinuclear membrane of ECs. M&B28767 increased eNOS RNA expression in EC nuclei, and this effect was augmented by overexpression of EP(3) receptors. M&B28767 also induced increased phosphorylation of Erk-1/2 and Akt, as well as changes in membrane potential revealed by the potentiometric fluorescent dye RH421, which were prevented by iberiotoxin; perinuclear K(Ca) channels were detected, and their functionality corroborated by NS1619-induced Ca(2+) signals and nuclear membrane potential changes. Moreover, pertussis toxin, Ca(2+) chelator, and channel blockers EGTA, BAPTA, and SK&F96365, as well as K(Ca) channel blocker iberiotoxin, protein-kinase inhibitors wortmannin and PD 98059, and NF-kappaB inhibitor pyrrolidine dithiocarbamate prevented M&B28767-induced increase in Ca(2+) transients and/or eNOS expression in EC nuclei. We describe for the first time that PGE(2) through its access into cell by prostaglandin transporters induces eNOS expression by activating perinuclear EP(3) receptors coupled to pertussis toxin-sensitive G proteins, a process that depends on nuclear envelope K(Ca) channels, protein kinases, and NF-kappaB; the roles for nuclear EP(3) receptors seem different from those on plasma membrane.
Gobeil
Fernand
F
Departments of Pediatrics, Research Center of Hôpital Sainte-Justine, Montréal.
Dumont
Isabelle
I
Marrache
Anne Marilise
AM
Vazquez-Tello
Alejandro
A
Bernier
Sylvie G
SG
Abran
Daniel
D
Hou
Xin
X
Beauchamp
Martin H
MH
Quiniou
Christiane
C
Bouayad
Asmaa
A
Choufani
Sanaa
S
Bhattacharya
Mousumi
M
Molotchnikoff
Stephane
S
Ribeiro-Da-Silva
Alfredo
A
Varma
Daya R
DR
Bkaily
Ghassan
G
Chemtob
Sylvain
S
D000818:Animals; D001921:Brain / Q000098:blood supply*; D002478:Cells, Cultured; D015232:Dinoprostone / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000502:physiology*; D008833:Microcirculation / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000235:genetics; D052250:Nitric Oxide Synthase Type III; D018078:Receptors, Prostaglandin E / Q000502:physiology*; D013552:Swine; D015854:Up-Regulation / Q000187:drug effects
D018078:Receptors, Prostaglandin E; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D015232:Dinoprostone